These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


72 related items for PubMed ID: 2739115

  • 21. Midodrine treatment for patients with hemodialysis hypotension.
    Flynn JJ, Mitchell MC, Caruso FS, McElligott MA.
    Clin Nephrol; 1996 Apr; 45(4):261-7. PubMed ID: 8861803
    [Abstract] [Full Text] [Related]

  • 22. [Usefulness of the Biofeedback Diacontrol module in the automatic programming of plasmatic conductivity and ionic mass transfer].
    Hernández-Jaras J, García-Pérez H, Torregrosa E, Calvo C, Cerrillo V.
    Nefrologia; 2003 Apr; 23(1):62-70. PubMed ID: 12708378
    [Abstract] [Full Text] [Related]

  • 23. Adrenergic regulation of blood pressure in chronic renal failure.
    Lilley JJ, Golden J, Stone RA.
    J Clin Invest; 1976 May; 57(5):1190-200. PubMed ID: 1262465
    [Abstract] [Full Text] [Related]

  • 24. Effect of cooled dialysate on serum catecholamines and blood pressure stability.
    Mahida BH, Dumler F, Zasuwa G, Fleig G, Levin NW.
    Trans Am Soc Artif Intern Organs; 1983 May; 29():384-9. PubMed ID: 6673258
    [Abstract] [Full Text] [Related]

  • 25. Could intradialytic hypotension be due to low baseline magnesium levels or inflammation in hemodialysis patients?
    Shin JI, Park SJ, Kim JH.
    Hemodial Int; 2011 Apr; 15(2):301-2. PubMed ID: 21352466
    [No Abstract] [Full Text] [Related]

  • 26. [Blood pressure and renin in long-term hemodialysis patients].
    Shin J, Sakai R, Nishioka M, Okudaira H, Arakawa T, Fujita Y, Komaba K, Nagai H.
    Nihon Jinzo Gakkai Shi; 1996 Jan; 38(1):13-21. PubMed ID: 8855132
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T.
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [Abstract] [Full Text] [Related]

  • 30. Effects of relative blood volume-controlled hemodialysis on blood pressure and volume status in hypertensive patients.
    Dasselaar JJ, Huisman RM, de Jong PE, Burgerhof JG, Franssen CF.
    ASAIO J; 2007 Jun; 53(3):357-64. PubMed ID: 17515729
    [Abstract] [Full Text] [Related]

  • 31. Central blood volume, atrial natriuretic peptide and intermittent hemodialysis.
    Wallin CJ, Rossi P, Jacobson SH, Leksell LG.
    Scand J Urol Nephrol; 2004 Jun; 38(1):78-84. PubMed ID: 15204432
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Dialysis-computer program. IV. Summary report. Epidemiology of complications].
    Degoulet P, Reach I, Aime F, Berger C, Goupy F, Jacobs C, Rojas P, Legrain M.
    J Urol Nephrol (Paris); 1977 Dec; 83(12):925-83. PubMed ID: 609111
    [Abstract] [Full Text] [Related]

  • 34. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
    Santoro A, Mancini E, Bolzani R, Boggi R, Cagnoli L, Francioso A, Fusaroli M, Piazza V, Rapanà R, Strippoli GF.
    Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
    [Abstract] [Full Text] [Related]

  • 35. [Clinical evaluation of serum albumin reductivity in patients with renal dysfunction: a comparison between conservative renal failure patients and hemodialysis patients].
    Suzuki Y, Aoki Y, Matsuyama Y, Hasegawa H, Shinohara Y, Hashimoto T, Era S, Soejima A.
    Nihon Jinzo Gakkai Shi; 2008 Sep; 50(4):513-20. PubMed ID: 18546883
    [Abstract] [Full Text] [Related]

  • 36. Elevated homocysteine levels in patients with end-stage renal disease.
    Nair AP, Nemirovsky D, Kim M, Geer EB, Farkouh ME, Winston J, Halperin JL, Robbins MJ.
    Mt Sinai J Med; 2005 Nov; 72(6):365-73. PubMed ID: 16358160
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Enhanced production of nitric oxide may be involved in acute hypotension during maintenance hemodialysis.
    Nishimura M, Takahashi H, Maruyama K, Ohtsuka K, Nanbu A, Hara K, Yoshimura M.
    Am J Kidney Dis; 1998 May; 31(5):809-17. PubMed ID: 9590191
    [Abstract] [Full Text] [Related]

  • 39. Changes in plasma catecholamine levels during hemodialysis.
    Frewin DB, Bartholomeusz FD, Cummings MF, Clarkson AR, Barry LA, Furber B, De Lorenzo C, Jonsson JR, Taylor WB.
    Aust N Z J Med; 1984 Feb; 14(1):31-4. PubMed ID: 6590002
    [Abstract] [Full Text] [Related]

  • 40. [Plasma catecholamine concentration and plasma dopamine-beta-hydroxylase activity in patients undergoing chronic hemodialysis (author's transl)].
    Sakuma H, Miura Y, Kobayashi K, Tomioka H, Adachi M, Furuyama T, Yoshinaga K, Sekino H, Ishizaki T.
    Nihon Jinzo Gakkai Shi; 1980 Jun; 22(6):753-62. PubMed ID: 7206334
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.